Annual Operating Expenses
$25.65 M
-$8.45 M-24.77%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual total operating expenses is $25.65 million, with the most recent change of -$8.45 million (-24.77%) on December 31, 2023.
- During the last 3 years, PBLA annual operating expenses has risen by +$19.89 million (+345.72%).
- PBLA annual operating expenses is now -24.77% below its all-time high of $34.09 million, reached on December 31, 2022.
Performance
PBLA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$7.17 M
-$938.00 K-11.58%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly total operating expenses is $7.17 million, with the most recent change of -$938.00 thousand (-11.58%) on September 30, 2024.
- Over the past year, PBLA quarterly operating expenses has increased by +$121.00 thousand (+1.72%).
- PBLA quarterly operating expenses is now -66.34% below its all-time high of $21.29 million, reached on June 30, 2022.
Performance
PBLA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PBLA Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.8% | +1.7% |
3 y3 years | +345.7% | +47.4% |
5 y5 years | +568.4% | +47.4% |
PBLA Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -24.8% | +156.2% | -66.3% | +116.4% |
5 y | 5-year | -24.8% | +493.4% | -66.3% | +572.1% |
alltime | all time | -24.8% | >+9999.0% | -66.3% | >+9999.0% |
Panbela Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $7.17 M(-11.6%) |
Jun 2024 | - | $8.10 M(+20.5%) |
Mar 2024 | - | $6.73 M(-4.5%) |
Dec 2023 | $25.65 M(-24.8%) | $7.04 M(-10.2%) |
Sep 2023 | - | $7.85 M(+33.5%) |
Jun 2023 | - | $5.88 M(+20.9%) |
Mar 2023 | - | $4.86 M(-6.2%) |
Dec 2022 | $34.09 M(+240.6%) | $5.18 M(+43.0%) |
Sep 2022 | - | $3.62 M(-83.0%) |
Jun 2022 | - | $21.29 M(+431.6%) |
Mar 2022 | - | $4.00 M(+20.9%) |
Dec 2021 | $10.01 M(+74.0%) | $3.31 M(+49.8%) |
Sep 2021 | - | $2.21 M(-0.7%) |
Jun 2021 | - | $2.23 M(-1.0%) |
Mar 2021 | - | $2.25 M(+40.4%) |
Dec 2020 | $5.75 M(+33.1%) | $1.60 M(-19.8%) |
Sep 2020 | - | $2.00 M(+80.8%) |
Jun 2020 | - | $1.10 M(+3.6%) |
Mar 2020 | - | $1.07 M(-14.0%) |
Dec 2019 | $4.32 M(+12.6%) | $1.24 M(-7.7%) |
Sep 2019 | - | $1.34 M(+23.3%) |
Jun 2019 | - | $1.09 M(+66.6%) |
Mar 2019 | - | $653.00 K(+3.0%) |
Dec 2018 | $3.84 M | $634.00 K(-28.6%) |
Sep 2018 | - | $888.00 K(-18.1%) |
Jun 2018 | - | $1.08 M(-11.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $1.23 M(-30.1%) |
Dec 2017 | $5.85 M(+13.3%) | $1.76 M(+72.5%) |
Sep 2017 | - | $1.02 M(-5.7%) |
Jun 2017 | - | $1.08 M(-45.9%) |
Mar 2017 | - | $1.99 M(-5.6%) |
Dec 2016 | $5.17 M(-5.1%) | $2.11 M(+86.1%) |
Sep 2016 | - | $1.14 M(+19.6%) |
Jun 2016 | - | $949.00 K(-2.7%) |
Mar 2016 | - | $975.00 K(-24.1%) |
Dec 2015 | $5.44 M(+58.0%) | $1.28 M(+66.8%) |
Sep 2015 | - | $770.00 K(-35.5%) |
Jun 2015 | - | $1.19 M(-45.4%) |
Mar 2015 | - | $2.18 M(+138.6%) |
Dec 2014 | $3.44 M(+465.0%) | $915.00 K(-17.9%) |
Sep 2014 | - | $1.11 M(+442.9%) |
Jun 2014 | - | $205.20 K(+95.4%) |
Mar 2014 | - | $105.00 K(-74.9%) |
Dec 2013 | $609.70 K(+136.2%) | $417.80 K(+496.0%) |
Sep 2013 | - | $70.10 K(+75.3%) |
Jun 2013 | - | $40.00 K(-47.2%) |
Mar 2013 | - | $75.80 K(+23.9%) |
Dec 2012 | $258.10 K(+1.7%) | $61.20 K(-4.1%) |
Sep 2012 | - | $63.80 K(-4.2%) |
Jun 2012 | - | $66.60 K(0.0%) |
Mar 2012 | - | $66.60 K |
Dec 2011 | $253.70 K | - |
FAQ
- What is Panbela Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Panbela Therapeutics?
- What is Panbela Therapeutics annual operating expenses year-on-year change?
- What is Panbela Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly operating expenses year-on-year change?
What is Panbela Therapeutics annual total operating expenses?
The current annual operating expenses of PBLA is $25.65 M
What is the all time high annual operating expenses for Panbela Therapeutics?
Panbela Therapeutics all-time high annual total operating expenses is $34.09 M
What is Panbela Therapeutics annual operating expenses year-on-year change?
Over the past year, PBLA annual total operating expenses has changed by -$8.45 M (-24.77%)
What is Panbela Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of PBLA is $7.17 M
What is the all time high quarterly operating expenses for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly total operating expenses is $21.29 M
What is Panbela Therapeutics quarterly operating expenses year-on-year change?
Over the past year, PBLA quarterly total operating expenses has changed by +$121.00 K (+1.72%)